Ophir, Yakir
Wong, Justin H.
Haddad, Katherine R.
Huuskonen, Anne
Karmaker, Anindya
Gore, Varun
Jung, Seongwon
Oloumi, Armin
Liu, Yiyun
Fu, Jingxin
Zhang, Libo
Huang, Peishan
Minami, Shiaki Arnett
Garimella, Shruthi Satya
Thyagatur, Anugraha
Zaini, Paulo A.
Vitikainen, Marika
Tchelet, Ronen
Valbuena, Noelia
Fuerst, Thomas R.
Korkmaz, Emrullah
Falo, Louis D. Jr
Balmert, Stephen C.
Mahendiratta, Saniya
Emalfarb, Mark
Shah, Priya S.
Siegel, Justin
Dandekar, Abhaya M.
Chen, Xi
Lebrilla, Carlito
Faller, Roland
Saloheimo, Markku
McDonald, Karen A.
Nandi, Somen
Funding for this research was provided by:
University of California, Davis (REGN10933)
University of California, Davis (S2H97)
National Institute of Standards and Technology (70NANB22H017)
U.S. Department of Commerce
Texas Tech University
National Institute of Allergy and Infectious Diseases
Rensselaer Polytechnic Institute
Johns Hopkins University
University of Texas at Austin
This article is maintained by: Elsevier
Article Title: Expression and characterization of SARS-CoV-2 spike protein in Thermothelomyces heterothallica C1
Journal Title: Vaccine
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.vaccine.2025.127784
Content Type: article
Copyright: © 2025 The Authors. Published by Elsevier Ltd.